{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:20:36Z","timestamp":1771237236517,"version":"3.50.1"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive lipid accumulation and has become the leading chronic liver disease worldwide. NAFLD is viewed as the hepatic manifestation of metabolic syndrome, ranging from simple steatosis and nonalcoholic steatohepatitis (NASH) to advanced fibrosis, eventually leading to cirrhosis and hepatocellular carcinoma (HCC). The pathogenesis of NAFLD progression is still not clear. Pattern recognition receptor (PRR)-mediated innate immune responses play a critical role in the initiation of NAFLD and the progression of NAFLD-related HCC. Toll-like receptors (TLRs) and the cyclic GMP-AMP (cGAMP) synthase (cGAS) are the two major PRRs in hepatocytes and resident innate immune cells in the liver. Increasing evidence indicates that the overactivation of TLRs and the cGAS signaling pathways may contribute to the development of liver disorders, including NAFLD progression. However, induction of PRRs is critical for the release of type I interferons (IFN-I) and the maturation of dendritic cells (DCs), which prime systemic antitumor immunity in HCC therapy. In this review, we will summarize the emerging evidence regarding the molecular mechanisms of TLRs and cGAS in the development of NAFLD and HCC. The dysfunction of PRR-mediated innate immune response is a critical determinant of NAFLD pathology; targeting and selectively inhibiting TLRs and cGAS signaling provides therapeutic potential for treating NALF-associated diseases in humans.<\/jats:p>","DOI":"10.3389\/fendo.2023.1145392","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T05:33:55Z","timestamp":1679290435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy"],"prefix":"10.3389","volume":"14","author":[{"given":"Chen","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiemin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diwen","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: when pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.livres.2020.02.004","article-title":"Nutrient mTORC1 signaling contributes to hepatic lipid metabolism in the pathogenesis of non-alcoholic fatty liver disease","volume":"4","author":"Chen","year":"2020","journal-title":"Liver Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2022.09.003","article-title":"Iron metabolism in nonalcoholic fatty liver disease: a promising therapeutic target","volume":"6","author":"Chen","year":"2022","journal-title":"Liver Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/17435390.2021.1919329","article-title":"Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload","volume":"15","author":"Zhu","year":"2021","journal-title":"Nanotoxicology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00407","article-title":"Rapamycin-loaded mPEG-PLGA nanoparticles ameliorate hepatic steatosis and liver injury in non-alcoholic fatty liver disease","volume":"8","author":"Zhao","year":"2020","journal-title":"Front Chem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2015.10.010","article-title":"Progression and natural history of nonalcoholic fatty liver disease in adults","volume":"20","author":"Marengo","year":"2016","journal-title":"Clin Liver Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: Basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.912178","article-title":"AgNPs aggravated hepatic steatosis, inflammation, oxidative stress, and epigenetic changes in mice with NAFLD induced by HFD","volume":"10","author":"Wen","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.10.015","article-title":"Current and emerging","volume":"68","author":"Konerman","year":"2018","journal-title":"J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/hep.29849","article-title":"DEP domain\u2013containing mTOR\u2013interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease","volume":"68","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig Dis Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12315","article-title":"Toll-like receptors and liver disease","volume":"34","author":"Kesar","year":"2014","journal-title":"Liver Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri3735","article-title":"Pattern recognition receptors: curbing gut inflammation","volume":"14","author":"Kugelberg","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2009.01.006","article-title":"Sensing pathogens and danger signals by the inflammasome","volume":"21","author":"Pedra","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2651","article-title":"Lipopolysaccharide-induced IL-18 secretion from murine kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta","volume":"166","author":"Seki","year":"2001","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis b virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J Virol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50182","article-title":"Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells","volume":"37","author":"Paik","year":"2003","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.709048","article-title":"Toll-like receptor 4 on macrophage promotes the development of steatohepatitis-related hepatocellular carcinoma in mice","volume":"291","author":"Miura","year":"2016","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121842","article-title":"STING-mediated inflammation in kupffer cells contributes to progression of nonalcoholic steatohepatitis","volume":"129","author":"Yu","year":"2019","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2018.07.011","article-title":"Toll-like receptor-7 signaling promotes nonalcoholic steatohepatitis by inhibiting regulatory T cells in mice","volume":"188","author":"Roh","year":"2018","journal-title":"Am J Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ijc.31029","article-title":"The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice","volume":"142","author":"Song","year":"2018","journal-title":"Int J Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/hep.32335","article-title":"Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway","volume":"77","author":"Ma","year":"2023","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1667\/RADE-21-00129.1","article-title":"The invasive potential of hepatoma cells induced by radiotherapy is related to the activation of hepatic stellate cells and could be inhibited by EGCG through the TLR4 signaling pathway","volume":"197","author":"Shen","year":"2022","journal-title":"Radiat Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16209","article-title":"Hepatic stellate cells specific liposomes with the toll-like receptor 4 shRNA attenuates liver fibrosis","volume":"25","author":"Zhang","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1755-1536-3-21","article-title":"Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis","volume":"3","author":"Guo","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0395-x","article-title":"DNA Sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury","volume":"18","author":"Du","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-1108-8","article-title":"The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma","volume":"39","author":"Thomsen","year":"2020","journal-title":"Oncogene"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12442","article-title":"Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease","volume":"35","author":"Kanuri","year":"2015","journal-title":"Liver Int"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.3390\/ijms17111878","article-title":"Increased expression profile and functionality of TLR6 in peripheral blood mononuclear cells and hepatocytes of morbidly obese patients with non-alcoholic fatty liver disease","volume":"17","author":"Arias-Loste","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-230X-10-52","article-title":"Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis","volume":"10","author":"Rivera","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26081","article-title":"Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice","volume":"57","author":"Miura","year":"2013","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"17815","DOI":"10.1038\/s41598-021-97346-9","article-title":"Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease","volume":"11","author":"Baumann","year":"2021","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00024.2006","article-title":"Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis","volume":"292","author":"Brun","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.770986","article-title":"Endotoxins and non-alcoholic fatty liver disease","volume":"12","author":"Kessoku","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01723.x","article-title":"Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis","volume":"28","author":"Farhadi","year":"2008","journal-title":"Liver Int"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1054\/clnu.2001.0529","article-title":"Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis","volume":"21","author":"de Almeida","year":"2002","journal-title":"Clin Nutr"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/1753425912436762","article-title":"Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence","volume":"18","author":"Soares","year":"2012","journal-title":"Innate Immun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J Hepatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.06.046","article-title":"The protein kinase IKKepsilon regulates energy balance in obese mice","volume":"138","author":"Chiang","year":"2009","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2018.01.007","article-title":"TBK1 at the crossroads of inflammation and energy homeostasis in adipose tissue","volume":"172","author":"Zhao","year":"2018","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160838","article-title":"TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival","volume":"131","author":"Mridha","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Garcia-Martinez","year":"2016","journal-title":"J Clin Invest"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41467-020-16092-0","article-title":"Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis","volume":"11","author":"An","year":"2020","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.613639","article-title":"TLR9 in MAFLD and NASH: At the intersection of inflammation and metabolism","volume":"11","author":"Shepard","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.06.024","article-title":"Nucleic acid-targeting pathways promote inflammation in obesity-related insulin resistance","volume":"16","author":"Revelo","year":"2016","journal-title":"Cell Rep"},{"key":"B65","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrc3283","article-title":"Inflammation: the gut takes a toll on liver cancer","volume":"12","author":"Alderton","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1074376","article-title":"TLR4 signaling promotes a COX-2\/PGE2\/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells","volume":"5","author":"Lin","year":"2016","journal-title":"Oncoimmunology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2070","article-title":"TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma","volume":"8","author":"Zhou","year":"2019","journal-title":"Cancer Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2021.1877346","article-title":"Prognostic role of TLR4 and TLR2 in hepatocellular carcinoma","volume":"60","author":"Kairaluoma","year":"2021","journal-title":"Acta Oncol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.05.031","article-title":"Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis","volume":"71","author":"Bonnin","year":"2019","journal-title":"J Hepatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2407-12-57","article-title":"The association between toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility","volume":"12","author":"Junjie","year":"2012","journal-title":"BMC Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"13582","DOI":"10.1038\/s41598-020-70137-4","article-title":"Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2\/NOX2\/autophagy axis","volume":"10","author":"Shiau","year":"2020","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.7150\/thno.44417","article-title":"Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma","volume":"10","author":"Zhou","year":"2020","journal-title":"Theranostics"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/apm.13142","article-title":"Toll-like receptor 5 and 8 in hepatocellular carcinoma","volume":"129","author":"Kairaluoma","year":"2021","journal-title":"APMIS"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227940","article-title":"TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects","volume":"15","author":"Haderski","year":"2020","journal-title":"PloS One"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7340","article-title":"Activation of the tolllike receptor 2 signaling pathway inhibits the proliferation of HCC cells in vitro","volume":"42","author":"Chen","year":"2019","journal-title":"Oncol Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.04.046","article-title":"Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase","volume":"153","author":"Gao","year":"2013","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/nature12306","article-title":"cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28685","article-title":"Lack of immunological DNA sensing in hepatocytes facilitates hepatitis b virus infection","volume":"64","author":"Thomsen","year":"2016","journal-title":"Hepatology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nature24050","article-title":"Cytoplasmic chromatin triggers inflammation in senescence and cancer","volume":"550","author":"Dou","year":"2017","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3586","article-title":"Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence","volume":"19","author":"Gluck","year":"2017","journal-title":"Nat Cell Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nature14156","article-title":"Mitochondrial DNA stress primes the antiviral innate immune response","volume":"520","author":"West","year":"2015","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e99238","DOI":"10.15252\/embj.201899238","article-title":"Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis","volume":"37","author":"Riley","year":"2018","journal-title":"EMBO J"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.11.036","article-title":"Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production","volume":"159","author":"White","year":"2014","journal-title":"Cell"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1006-9","article-title":"Autophagy induction via STING trafficking is a primordial function of the cGAS pathway","volume":"567","author":"Gui","year":"2019","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180139","article-title":"The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer","volume":"215","author":"Li","year":"2018","journal-title":"J Exp Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.2337\/dbi18-0052","article-title":"The cGAS-cGAMP-STING pathway: A molecular link between immunity and metabolism","volume":"68","author":"Bai","year":"2019","journal-title":"Diabetes"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA Sensing by the cGAS-STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-019-0342-6","article-title":"STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease","volume":"100","author":"Wang","year":"2020","journal-title":"Lab Invest"},{"key":"B91","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.metabol.2017.09.010","article-title":"Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease","volume":"81","author":"Qiao","year":"2018","journal-title":"Metabolism"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00326.2017","article-title":"cGAS-mediated autophagy protects the liver from ischemia-reperfusion injury independently of STING","volume":"314","author":"Lei","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30834","article-title":"The role of senescence in the development of nonalcoholic fatty liver disease and progression to nonalcoholic steatohepatitis","volume":"71","author":"Papatheodoridi","year":"2020","journal-title":"Hepatology"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309017","article-title":"STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity","volume":"37","author":"Mao","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.03.034","article-title":"Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING","volume":"526","author":"Li","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323426","article-title":"Lactobacillus rhamnosus GG induces cGAS\/STING- dependent type I interferon and improves response to immune checkpoint blockade","volume":"71","author":"Si","year":"2022","journal-title":"Gut"},{"key":"B97","doi-asserted-by":"publisher","first-page":"BSR20202603","DOI":"10.1042\/BSR20202603","article-title":"Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma","volume":"40","author":"Qi","year":"2020","journal-title":"Biosci Rep"},{"key":"B98","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"cGAS-STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Cancer"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2018.1499722","article-title":"Recent developments with immunotherapy for hepatocellular carcinoma","volume":"18","author":"Waidmann","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.01.036","article-title":"Maintaining manganese in tumor to activate cGAS-STING pathway evokes a robust abscopal anti-tumor effect","volume":"331","author":"Wang","year":"2021","journal-title":"J Control Release"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.11.017","article-title":"Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration","volume":"330","author":"Wehbe","year":"2021","journal-title":"J Control Release"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202100068","article-title":"E7766, a macrocycle-bridged stimulator of interferon genes (STING) agonist with potent pan-genotypic activity","volume":"16","author":"Kim","year":"2021","journal-title":"ChemMedChem"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.11.035","article-title":"Interferon-beta signal may up-regulate PD-L1 expression through IRF9-dependent and independent pathways in lung cancer cells","volume":"507","author":"Morimoto","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1016\/j.celrep.2019.11.113","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"29","author":"Garcia-Diaz","year":"2019","journal-title":"Cell Rep"},{"key":"B106","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13075-020-2097-2","article-title":"Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug","volume":"22","author":"Samarpita","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B107","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41467-017-00833-9","article-title":"Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice","volume":"8","author":"Vincent","year":"2017","journal-title":"Nat Commun"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1145392\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T05:33:58Z","timestamp":1679290438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1145392\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":107,"alternative-id":["10.3389\/fendo.2023.1145392"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1145392","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]},"article-number":"1145392"}}